Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AMC ENTERTAINMENT HOLDINGS, INC. (AMC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

AMC ENTERTAINMENT HOLDINGS, INC.Trade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

AMC ENTERTAINMENT HOLDINGS, INC. vs Neurocrine Biosciences Inc — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.39 (market cap $2.14B), while Neurocrine Biosciences Inc trades at $157.76 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 7.7× AMC ENTERTAINMENT HOLDINGS, INC.'s market cap, and AMC ENTERTAINMENT HOLDINGS, INC. pays a 0.11% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

AMCNBIX
Market Cap
$2.14B$16.46B
Sector
MediaHealth
52-Week High
$3.15$185.50
52-Week Low
$0.95$123.10
Enterprise Value
$9.08B$16.48B
Dividend Yield
0.11%

Returns comparison

Trailing returns across standard periods

About AMC ENTERTAINMENT HOLDINGS, INC.

AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.

Read more on AMC

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX